These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12034146)

  • 21. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
    Urbanová D; Mladosievicová B
    Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiotoxicity of chemotherapeutic drugs.
    Allen A
    Semin Oncol; 1992 Oct; 19(5):529-42. PubMed ID: 1411651
    [No Abstract]   [Full Text] [Related]  

  • 23. [Promote multidisciplinary study on anthracycline-induced cardiotoxicity in children].
    Chen SB; Huang MR; Tang JY
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):565-8. PubMed ID: 24225284
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
    Hernandez-Suarez DF; López-Candales A
    Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiotoxicity of antineoplastic anthracycline antibiotics and prevention by cardioxane (Dexrazoxane) in clinical practice].
    Gershanovich ML
    Vopr Onkol; 2001; 47(1):119-22. PubMed ID: 11317530
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
    Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
    J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Laursen AH; Thune JJ; Hutchings M; Hasbak P; Kjaer A; Elming MB; Ripa RS
    Clin Physiol Funct Imaging; 2018 Mar; 38(2):176-185. PubMed ID: 28251781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
    Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
    Gramatyka M
    Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
    Scully RE; Lipshultz SE
    Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiotoxicity of systemic agents used in breast cancer.
    Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
    Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
    Ky B; Carver JR
    Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion].
    Orditura M; De Vita F; Ciaramella F; Catalano G
    Ann Ital Med Int; 1994; 9(4):243-8. PubMed ID: 7893575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy-induced cardiac toxicity and management].
    Komagata H; Sakai H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of Cardiotoxicities With Traditional and Novel Chemotherapeutic Agents.
    Sharalaya Z; Collier P
    Curr Heart Fail Rep; 2018 Aug; 15(4):260-269. PubMed ID: 29938321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiotoxicity of cytotoxic drugs.
    Schimmel KJ; Richel DJ; van den Brink RB; Guchelaar HJ
    Cancer Treat Rev; 2004 Apr; 30(2):181-91. PubMed ID: 15023436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
    Ghigo A; Li M; Hirsch E
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and prevention of cardiac complications of cancer chemotherapy.
    Monsuez JJ
    Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiotoxicity of cytotoxic chemotherapy and its prevention.
    Selvaratnam G; Philips RH; Mohamed AK
    Adverse Drug React Toxicol Rev; 1999 Jun; 18(2):61-105. PubMed ID: 10478286
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiotoxicity and pulmonary toxicity of chemotherapy].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):934-41. PubMed ID: 2188614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.